W

hat does the cost of a drug say about society’s values? And what is the market willing to pay for?

That’s a loaded question, to be sure, but a new report from life sciences consultancy Trinity Partners tries to dissect the issue a bit.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.